ALK and ovarian cancer: We also found that in 79 samples (of which 62 were central nervous system (CNS) tumors, seven were ovarian cancers, five were NSCLC, and five were other cancers), all ALK exons were transcribed, indicating the increased expression of the wild-type gene.